{"id":250,"date":"2019-11-14T20:34:56","date_gmt":"2019-11-15T01:34:56","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-11-anticholinergics\/"},"modified":"2023-08-15T13:01:46","modified_gmt":"2023-08-15T17:01:46","slug":"5-11-anticholinergics","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-11-anticholinergics\/","title":{"raw":"5.11 Anticholinergics","rendered":"5.11 Anticholinergics"},"content":{"raw":"<h1>Anticholinergics<\/h1>\r\nIpratropium is an example of a short-acting anticholinergic. Tiotropium is an example of a long-acting anticholinergic. Additional information regarding anticholinergics can be found in the \"Autonomic Nervous System\" chapter. (See Figure 5.11[footnote]\"Spiriva HandiHaler\"-brand dry powder inhaler (open).png\" by <a href=\"https:\/\/en.wikipedia.org\/wiki\/User:RonEJ\" rel=\"noopener noreferrer\">RonEJ<\/a> at <a href=\"https:\/\/en.wikipedia.org\/wiki\/\" rel=\"noopener noreferrer\">English Wikipedia<\/a> is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/\" rel=\"noopener noreferrer\">CC0 1.0<\/a>[\/footnote] for an image of tiotropium.)\r\n\r\n[caption id=\"attachment_248\" align=\"aligncenter\" width=\"555\"]<img class=\"wp-image-248\" title=\"&quot;Spiriva HandiHaler&quot;-brand dry powder inhaler (open).png&quot; by RonEJ at English Wikipedia is licensed under CC0 1.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8.png\" alt=\"Spiriva HandiHaler, a dry powder inhaler.\" width=\"555\" height=\"503\" \/> Figure 5.11 Tiotropium, a long-acting anticholinergic[\/caption]\r\n<h2>Mechanism of Action<\/h2>\r\nAnticholinergics block the action of acetylcholine in bronchial smooth muscle, which reduces Broncho-constrictive substance release.\r\n<h2>Indications for Use<\/h2>\r\nAnticholinergics are used for maintenance therapy of bronchoconstriction associated with asthma, chronic bronchitis, and emphysema.\r\n<h2>Adverse\/Side Effects<\/h2>\r\nAnticholinergics should be used with caution with the elderly and can cause cough, drying of the nasal mucosa, nervousness, nausea, GI upset, headaches, and dizziness.[footnote]Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer.[\/footnote]\r\n<h2><span style=\"font-size: 18.6667px;\">Anticholinergic<\/span>\u00a0Drugs across the Life Span<\/h2>\r\nWheezing is an indication for using anticholinergic drugs but although we do see wheezing in infancy, using these drugs remains controversial.\u00a0 Most wheezing in infancy is in response to viral infections.\r\n<h2>Client Teaching &amp; Education<\/h2>\r\nClient should be instructed to use the inhaler as directed and be careful not to exceed dosage recommendations. They should receive education regarding the onset of medication and differences in usage for short- and long-acting anticholinergics. Clients with certain diseases should not use anticholinergics including Myasthenia gravis, hyperthyroidism, glaucoma, enlarged prostate, hypertension, urinary tract blockage, tachycardia and heart failure. Some long-acting anticholinergics may cause signs of angioedema and the healthcare provider should be notified if this occurs.[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n<h1>Ipratropium and Tiotropium Medication Card<\/h1>\r\nNow let's take a closer look at the medication card for ipratropium and tiotropium.[footnote]This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0licensed under\u00a0<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>.[\/footnote],[footnote]Frandsen, G. &amp; Pennington, S. (2018).\u00a0<em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer.[\/footnote], [footnote]This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a>\u00a0in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>. [\/footnote],[footnote]Adams, M., Holland, N., &amp; Urban, C. (2020).\u00a0<em style=\"font-size: 1em;\">Pharmacology for nurses: A pathophysiologic approach\u00a0<\/em><span style=\"font-size: 1em;\">(6th ed.). pp. 622-63 &amp; 626. Pearson. [\/footnote]<\/span>\r\n<div class=\"textbox textbox--learning-objectives\"><header class=\"textbox__header\">\r\n<h2 class=\"textbox__title\">Medication Card 5.11.1: Ipratropium and Tiotropium<\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n\r\n<strong>Class: <\/strong>Anticholinergics\r\n\r\n<strong>Prototypes: <\/strong>Ipratropium \u00a0(short acting anticholinergic)\r\n\r\n<strong>Tiotropium (long acting anticholinergic)<\/strong>\r\n\r\n<strong>Mechanism:\u00a0 <\/strong>Anticholinergics block the action of acetylcholine in bronchial smooth muscle, which reduces Broncho-constrictive substance release\r\n<h3>Therapeutic Effects<\/h3>\r\n<ul>\r\n \t<li>Rapid bronchodilation to improve air movement and gas exchange<\/li>\r\n \t<li>In long acting anticholinergics the prevention of bronchospasm and reduced exacerbation in COPD symptoms<\/li>\r\n<\/ul>\r\n<h3>Administration<\/h3>\r\n<ul>\r\n \t<li>Inhaler use should be done with proper technique to get appropriate dosages<\/li>\r\n \t<li>This can also be administered via a nebulizer. A nebulizer is a device such as a face mask that nurses place the liquid form of ipratropium in and attaches it to forced air which blows the medication through steam for 5-15 mins during inhalation.\u00a0 Typically doses are given 3-4 times per day. This is normally given in the hospital setting. The mask must be cleaned after use and the mouth should be rinsed.<\/li>\r\n<\/ul>\r\n<h3>Indications<\/h3>\r\n<ul>\r\n \t<li>Anticholinergics are used for maintenance therapy of bronchoconstriction associated with asthma, chronic bronchitis, and emphysema<\/li>\r\n \t<li>Wheezing<\/li>\r\n<\/ul>\r\n<h3>Contraindications<\/h3>\r\n<ul>\r\n \t<li>Although we can see wheezing with infants this drug is not really used<\/li>\r\n \t<li>Do not use if having Myasthenia gravis, hyperthyroid, glaucoma, enlarge prostate, urinary blockage tachycardia and heart failure<\/li>\r\n<\/ul>\r\n<h3>Side Effects<\/h3>\r\n<ul>\r\n \t<li>Increase cough<\/li>\r\n \t<li>Drying of nasal mucosa<\/li>\r\n \t<li>Nervousness<\/li>\r\n \t<li>Nausea and GI upset<\/li>\r\n \t<li>Headaches<\/li>\r\n \t<li>Dizziness<\/li>\r\n \t<li>Long term use may lead to angioedema<\/li>\r\n<\/ul>\r\n<strong>Safety: <\/strong>Understanding how to manage breathing concerns early and when a medical emergency and support is needed\r\n<h3>Nursing Considerations<\/h3>\r\n<ul>\r\n \t<li>Watch for signs and symptoms of side effects including angioedema such as swelling in face<\/li>\r\n \t<li>For quick relief breathing it is best used regularly as Salbutamol also known as albuterol is mostly known for its fast effects<\/li>\r\n<\/ul>\r\n<\/div>\r\n<\/div>","rendered":"<h1>Anticholinergics<\/h1>\n<p>Ipratropium is an example of a short-acting anticholinergic. Tiotropium is an example of a long-acting anticholinergic. Additional information regarding anticholinergics can be found in the &#8220;Autonomic Nervous System&#8221; chapter. (See Figure 5.11<a class=\"footnote\" title=\"&quot;Spiriva HandiHaler&quot;-brand dry powder inhaler (open).png&quot; by RonEJ at English Wikipedia is licensed under CC0 1.0\" id=\"return-footnote-250-1\" href=\"#footnote-250-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a> for an image of tiotropium.)<\/p>\n<figure id=\"attachment_248\" aria-describedby=\"caption-attachment-248\" style=\"width: 555px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-248\" title=\"&quot;Spiriva HandiHaler&quot;-brand dry powder inhaler (open).png&quot; by RonEJ at English Wikipedia is licensed under CC0 1.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8.png\" alt=\"Spiriva HandiHaler, a dry powder inhaler.\" width=\"555\" height=\"503\" srcset=\"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8.png 938w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8-300x272.png 300w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8-768x696.png 768w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8-65x59.png 65w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8-225x204.png 225w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image3-8-350x317.png 350w\" sizes=\"auto, (max-width: 555px) 100vw, 555px\" \/><figcaption id=\"caption-attachment-248\" class=\"wp-caption-text\">Figure 5.11 Tiotropium, a long-acting anticholinergic<\/figcaption><\/figure>\n<h2>Mechanism of Action<\/h2>\n<p>Anticholinergics block the action of acetylcholine in bronchial smooth muscle, which reduces Broncho-constrictive substance release.<\/p>\n<h2>Indications for Use<\/h2>\n<p>Anticholinergics are used for maintenance therapy of bronchoconstriction associated with asthma, chronic bronchitis, and emphysema.<\/p>\n<h2>Adverse\/Side Effects<\/h2>\n<p>Anticholinergics should be used with caution with the elderly and can cause cough, drying of the nasal mucosa, nervousness, nausea, GI upset, headaches, and dizziness.<a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice (11th ed.). Wolters Kluwer.\" id=\"return-footnote-250-2\" href=\"#footnote-250-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/p>\n<h2><span style=\"font-size: 18.6667px;\">Anticholinergic<\/span>\u00a0Drugs across the Life Span<\/h2>\n<p>Wheezing is an indication for using anticholinergic drugs but although we do see wheezing in infancy, using these drugs remains controversial.\u00a0 Most wheezing in infancy is in response to viral infections.<\/p>\n<h2>Client Teaching &amp; Education<\/h2>\n<p>Client should be instructed to use the inhaler as directed and be careful not to exceed dosage recommendations. They should receive education regarding the onset of medication and differences in usage for short- and long-acting anticholinergics. Clients with certain diseases should not use anticholinergics including Myasthenia gravis, hyperthyroidism, glaucoma, enlarged prostate, hypertension, urinary tract blockage, tachycardia and heart failure. Some long-acting anticholinergics may cause signs of angioedema and the healthcare provider should be notified if this occurs.<a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-250-3\" href=\"#footnote-250-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/p>\n<h1>Ipratropium and Tiotropium Medication Card<\/h1>\n<p>Now let&#8217;s take a closer look at the medication card for ipratropium and tiotropium.<a class=\"footnote\" title=\"This work is a derivative of\u00a0Pharmacology Notes: Nursing Implications for Clinical Practice\u00a0by\u00a0Gloria Velarde\u00a0licensed under\u00a0CC BY-NC-SA 4.0.\" id=\"return-footnote-250-4\" href=\"#footnote-250-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a>,<a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018).\u00a0Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0(11th ed.). Wolters Kluwer.\" id=\"return-footnote-250-5\" href=\"#footnote-250-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a>, <a class=\"footnote\" title=\"This work is a derivative of\u00a0Daily Med\u00a0by\u00a0U.S. National Library of Medicine\u00a0in the public domain.\" id=\"return-footnote-250-6\" href=\"#footnote-250-6\" aria-label=\"Footnote 6\"><sup class=\"footnote\">[6]<\/sup><\/a>,<a class=\"footnote\" title=\"Adams, M., Holland, N., &amp; Urban, C. (2020).\u00a0Pharmacology for nurses: A pathophysiologic approach\u00a0(6th ed.). pp. 622-63 &amp; 626. Pearson.\" id=\"return-footnote-250-7\" href=\"#footnote-250-7\" aria-label=\"Footnote 7\"><sup class=\"footnote\">[7]<\/sup><\/a><\/span><\/p>\n<div class=\"textbox textbox--learning-objectives\">\n<header class=\"textbox__header\">\n<h2 class=\"textbox__title\">Medication Card 5.11.1: Ipratropium and Tiotropium<\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<p><strong>Class: <\/strong>Anticholinergics<\/p>\n<p><strong>Prototypes: <\/strong>Ipratropium \u00a0(short acting anticholinergic)<\/p>\n<p><strong>Tiotropium (long acting anticholinergic)<\/strong><\/p>\n<p><strong>Mechanism:\u00a0 <\/strong>Anticholinergics block the action of acetylcholine in bronchial smooth muscle, which reduces Broncho-constrictive substance release<\/p>\n<h3>Therapeutic Effects<\/h3>\n<ul>\n<li>Rapid bronchodilation to improve air movement and gas exchange<\/li>\n<li>In long acting anticholinergics the prevention of bronchospasm and reduced exacerbation in COPD symptoms<\/li>\n<\/ul>\n<h3>Administration<\/h3>\n<ul>\n<li>Inhaler use should be done with proper technique to get appropriate dosages<\/li>\n<li>This can also be administered via a nebulizer. A nebulizer is a device such as a face mask that nurses place the liquid form of ipratropium in and attaches it to forced air which blows the medication through steam for 5-15 mins during inhalation.\u00a0 Typically doses are given 3-4 times per day. This is normally given in the hospital setting. The mask must be cleaned after use and the mouth should be rinsed.<\/li>\n<\/ul>\n<h3>Indications<\/h3>\n<ul>\n<li>Anticholinergics are used for maintenance therapy of bronchoconstriction associated with asthma, chronic bronchitis, and emphysema<\/li>\n<li>Wheezing<\/li>\n<\/ul>\n<h3>Contraindications<\/h3>\n<ul>\n<li>Although we can see wheezing with infants this drug is not really used<\/li>\n<li>Do not use if having Myasthenia gravis, hyperthyroid, glaucoma, enlarge prostate, urinary blockage tachycardia and heart failure<\/li>\n<\/ul>\n<h3>Side Effects<\/h3>\n<ul>\n<li>Increase cough<\/li>\n<li>Drying of nasal mucosa<\/li>\n<li>Nervousness<\/li>\n<li>Nausea and GI upset<\/li>\n<li>Headaches<\/li>\n<li>Dizziness<\/li>\n<li>Long term use may lead to angioedema<\/li>\n<\/ul>\n<p><strong>Safety: <\/strong>Understanding how to manage breathing concerns early and when a medical emergency and support is needed<\/p>\n<h3>Nursing Considerations<\/h3>\n<ul>\n<li>Watch for signs and symptoms of side effects including angioedema such as swelling in face<\/li>\n<li>For quick relief breathing it is best used regularly as Salbutamol also known as albuterol is mostly known for its fast effects<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-250-1\">\"Spiriva HandiHaler\"-brand dry powder inhaler (open).png\" by <a href=\"https:\/\/en.wikipedia.org\/wiki\/User:RonEJ\" rel=\"noopener noreferrer\">RonEJ<\/a> at <a href=\"https:\/\/en.wikipedia.org\/wiki\/\" rel=\"noopener noreferrer\">English Wikipedia<\/a> is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/\" rel=\"noopener noreferrer\">CC0 1.0<\/a> <a href=\"#return-footnote-250-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-250-2\">Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-250-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-250-3\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-250-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-250-4\">This work is a derivative of\u00a0<a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a>\u00a0licensed under\u00a0<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>. <a href=\"#return-footnote-250-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-250-5\">Frandsen, G. &amp; Pennington, S. (2018).\u00a0<em>Abrams\u2019 clinical drug: Rationales for nursing practice\u00a0<\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-250-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><li id=\"footnote-250-6\">This work is a derivative of\u00a0<a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a>\u00a0by\u00a0<a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a>\u00a0in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>.  <a href=\"#return-footnote-250-6\" class=\"return-footnote\" aria-label=\"Return to footnote 6\">&crarr;<\/a><\/li><li id=\"footnote-250-7\">Adams, M., Holland, N., &amp; Urban, C. (2020).\u00a0<em style=\"font-size: 1em;\">Pharmacology for nurses: A pathophysiologic approach\u00a0<\/em><span style=\"font-size: 1em;\">(6th ed.). pp. 622-63 &amp; 626. Pearson.  <a href=\"#return-footnote-250-7\" class=\"return-footnote\" aria-label=\"Return to footnote 7\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":90,"menu_order":11,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[50],"contributor":[],"license":[],"class_list":["post-250","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":209,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":5,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/250\/revisions"}],"predecessor-version":[{"id":1733,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/250\/revisions\/1733"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/209"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/250\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=250"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=250"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=250"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}